Eicke Latz studied medicine in Göttingen and Berlin and worked as an intensive care physician at the Charité Hospital in Berlin. Starting 2000 he received post-doctoral training at Boston University and UMass Medical School, where he joined the UMass faculty in 2006. In 2010 he returned to Germany and founded the Institute of Innate Immunity at the University of Bonn. His laboratory focuses on identifying the most proximal mechanisms of innate immune activation involved in mediating chronic inflammatory diseases. Using systems approaches that decipher how lifestyle-associated factors trigger and maintain chronic inflammation and disease development, his lab uncovers novel therapeutic targets. Eicke has co-founded IFM Therapeutics, DiosCure Therapeutics and a 'Stealth' biotech which translate discoveries into novel therapeutics. He is a highly cited scientist in immunology yearly since 2014, and he has received prestigious awards, such as the Gottfried Wilhelm Leibniz Prize in 2018.
2001 Doctorate, Medicine, Humboldt University of Berlin
1993-1998 Studies of Medicine, State examination, Free University of Berlin
1991-1993 Studies of Medicine, University of Göttingen
2014-present Full Professor of Medicine, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA
2011-present Group leader, Innate Immunity in Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn
2009-present W3 Professor and Director, Institute of Innate Immunity, University Hospital Bonn
2008-present Adjunct Professor II, Center for Molecular Inflammation Research (CEMIR), Norwegian University of Science and Technology, Trondheim, Norway
2006-2013 Assistant Professor of Medicine, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA
2003-2006 Assistant Research Professor of Medicine, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA
2001-2003 Postdoctoral fellow, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA
2022-present ERC panel member LS6–Immunity, Infection and Immunotherapy
2021-present Co-founder and consultant, Odyssey Therapeutics, Boston, MA, USA
2020-present Elected member, ‘Hochschulrat’ (Supervisory Board), University of Bonn
2020-present Co-founder, chair of the board, Dioscure SE, Bonn, Germany
2020-present Co-founder, SAB chair, board member, Stealth Biotech, Hollywood, CA, USA
2018-present Co-speaker, Cluster of Excellence “ImmunoSensation2", University of Bonn
2018 Gottfried Wilhelm Leibniz Prize
2016-present Member, Helmholtz Think Tank, Helmholtz Society, Berlin
2016-present Scientific co-founder and consultant, IFM Therapeutics, Boston, MA, USA
2016-present Elected member, German National Academy of Sciences (Leopoldina)
2015-present Chair, Scientific Advisory Board, MPI for Infection Biology, Berlin
2015-present Member, German Society for Immunology(DGFI)
2014-2022 Listed in the ‘World’s Most Influential Scientific Minds’ (Thomson Reuters), Highly Cited Researcher in Immunology
2014-present Kavli Fellow of the United States National Academy of Sciences (NAS)
2013 ERC Consolidator Grant “InflammAct“
2012-present Member, American Association of Immunologists (AAI)
2012-2018 Member, Cluster of Excellence “ImmunoSensation”, University of Bonn
2011 Glaxo Smith Kline Clinical Science Award
2010-present Founding member, International Trained Immunity Consortium (INTRIM)
2009 Dana Foundation Award
2004 Federation of Clinical Immunology Societies (FOCIS) Award
2001 Postdoctoral Grant of the German Academic Exchange Service (DAAD)
2000 Scholarship of the Japanese Society for Endoscopy
1999 Scholarship of the Monika Kutzner Foundation
